Summary
Dr Jaideep Dhariwal is a Clinical Research Fellow within the Airway Disease Infection group at the National Heart & Lung Institute, Imperial College London.
Jaideep graduated from Imperial College School of Medicine in 2006. He intercalated with a BSc in Haematology (2004) for which he was awarded first class honours and the Steadman and Freda-Becker awards for best Haematology Bsc and overall BSc performance.
In 2011 he was appointed to the post of Academic Clinical Fellow in Respiratory Medicine at Imperial College. He spent his first year as a Respiratory SpR at Charing Cross, St. Mary’s and the Hammersmith Hospitals.
Jaideep is currently the clinical research fellow working on the MRC/GSK Strategic Alliance – a ~£6M venture investigating the mechanisms of interplay between allergy and viruses in asthma. As part of this he is undertaking a PhD looking at mechanisms of virus-induced asthma exacerbations, working under the supervision of Professor Sebastian Johnston.
Publications
Journals
Dhariwal J, Cameron A, Wong E, et al., 2021, Pulmonary innate lymphoid cell responses during rhinovirus-induced asthma exacerbations, Journal of Allergy and Clinical Immunology, Vol:204, ISSN:0091-6749, Pages:1259-1273
Hearn AP, Hug OD, Somani ZA, et al., 2021, Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy., Eur Respir J, Vol:57
Kavanagh JE, Hearn AP, Dhariwal J, et al., 2021, Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma, Chest, Vol:159, ISSN:0012-3692, Pages:496-506
Nanzer AM, Dhariwal J, Kavanagh J, et al., 2020, Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis, Erj Open Research, Vol:6
Kavanagh JE, d'Ancona G, Elstad M, et al., 2020, Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic Asthma, Chest, Vol:158, ISSN:0012-3692, Pages:491-500